CLINICAL_TRIALS
trial_result
· 2018-08-27
Clinical Trial Update: Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya [Phase 3]
Summary
Phase 3 clinical trial update evaluating optimized pediatric HIV-1 treatment in infants with prophylactic exposure to nevirapine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Washington | Conditions: HIV Infections | Phase 3 | Status: TERMINATED | Results posted: 2018-08-27